A Dose Is Not a Diagnosis | The Pained Brain, Chapter 17

What is MME · opioid dose

What Is MME? The Number on Your Chart and What It Misses

MME stands for morphine milligram equivalents, a conversion that restates each opioid you take as if it were morphine so doses can be compared. It measures exposure on paper, not how your body handles the drug: enzyme type, insulin and body fat never appear in it.

Morphine milligram equivalents turn a medication list into one daily figure. That figure can decide a pharmacy alert or a quality score, yet it records nothing about the body the medicine enters.

What is MME? The letters stand for morphine milligram equivalents, a conversion that restates every opioid on a medication list as if it were morphine and then adds the results into one daily figure. For many people with chronic pain, that figure sits higher in the record than blood sugar, body composition or the joint that actually hurts. The video A Dose Is Not a Diagnosis, Chapter 17 of The Pained Brain by Dr. Gurpreet Singh Padda, MD, MBA, MHP, and Dr. KrisJay Fucanan, MD, follows a man whose care was steered by that figure for six years. The angle here is measurement: what the total captures, what it cannot, and what else about your body can be measured and set beside it. The full study list sits in the book companion for Chapter 17.

What is MME, and why does a common unit exist?

Opioids differ in strength, so a shared unit lets a physician, a pharmacist and a health plan talk about the same exposure. The risk behind the unit is not imaginary. Among 9,940 people treated for chronic pain in a Washington health plan, the group taking 100 milligrams a day or more overdosed at 8.9 times the rate of the group at 1 to 20. Read that paper for its absolute rates and the scale shifts: roughly 0.2 percent a year at the lowest dose against 1.8 percent at the highest, and most overdoses happened at low to moderate doses. Pooled dose studies found risk starting to rise at 20 milligrams a day, which describes a gradual slope with no cliff at any one line. A slope can be handled with judgment. A single cutoff on a chart invites the opposite.

Is an MME total calculated the same way every time?

A measurement is only as good as its repeatability, and here the MME total struggles. Handed identical doses to convert, 319 clinicians returned a mean of 176 milligrams for a 75-microgram fentanyl patch, spread by a standard deviation of 117; methadone at 40 milligrams came back at 193, spread by 201. Eight online calculators disagreed about one dose by anywhere from −55 to +242 percent. The 2022 federal guideline adds two facts that matter at the pharmacy counter: no dosage threshold makes risk disappear, and buprenorphine should not be added into the daily total at all. If two careful professionals can land a hundred milligrams apart on one chart, the number that triggers a letter or an alert carries error nobody prints beside it. Any laboratory result with that much scatter would come with a range attached.

Does every body handle the same opioid dose the same way?

A dose on paper is not the dose that reaches the receptor. Codeine and tramadol stay inactive until a liver enzyme, CYP2D6, converts them. People with little working enzyme, called poor metabolizers, make 96 percent less morphine from the same codeine dose, while ultrarapid metabolizers make 45 percent more. How common each type is depends on ancestry: 2.3 percent of sequenced participants across sub-Saharan Africa were predicted poor metabolizers, and 6.4 percent in Botswana. Genotyping that enzyme is a separate genetic test done elsewhere; Measura [Cardiometabolic and Autonomic Health Analysis], the testing service behind this site, does not offer it.

The second driver is metabolic. After hip and knee replacement, the effect of an opioid receptor gene on morphine requirement ran in opposite directions depending on whether the patient had diabetes. The effect was small, since gene, diabetes and their interaction explained 2.7 percent of the variation in dose, but a fixed line assumes the direction never flips. Body fat adds another layer: a review of dosing in obesity describes excess adiposity changing how drugs distribute and clear. Insulin and fat mass are both measurable, and neither appears in an MME total.

What predicts overdose better than the MME total?

In a Medicare cohort, safety rules built on dose caught 29.29 percent of the people who later overdosed. A prediction model that combined dose with 267 other variables caught 90 percent. Dose ranked first among those predictors and was still one of 268. Among people filling a first opioid prescription, those with a substance-use disorder carried 2.74 times the overdose risk, those older than 75 carried 3.22 times, and adding a benzodiazepine multiplied the hazard by 5.05 during the first 90 days. In Massachusetts, only 20.5 percent of fatal opioid overdoses followed any high-risk prescription pattern. Dose is not harmless. A record organized around one number is simply organized around the least complete description of the person.

What a standard visit records, and what it skips

For the man in the video, a dose total governed six years of decisions. Nobody tracked his hemoglobin A1c, or the two facet joints and the sacroiliac joint that diagnostic blocks later showed were producing most of his pain. When someone finally measured the terrain, his fasting insulin was 31 and a sleep study found apnea. His physician had been flagged by a health plan for how many patients sat above a line, and that is the social driver in the story: an incentive that rewards counting a milligram over finding a cause. How an injection result can mislead is covered in what a failed injection does and does not prove.

Measura measures; it does not treat, prescribe or change medication, and every finding goes to your physician. Three kinds of measurement fit the gaps above:

Metabolic blood work. Laboratory panels can include markers of blood sugar and insulin, the terrain that changes how a medicine behaves.
Body composition. Bioimpedance body composition separates fat from lean tissue instead of inferring both from weight, and body composition is not the same as weight.
The wider picture. How pain and metabolism feed each other is laid out in chronic pain and metabolic health.

A sleep study is a different test done elsewhere, and so is locating a pain generator with diagnostic blocks. The measurement task is making sure those questions get asked at all.

Questions to bring to your physician

Nothing here is a reason to change a dose on your own; any change belongs in a written plan with the physician who prescribes. The evidence does say the manner of change matters: among people on long-term treatment, reductions faster than 30 percent a month carried a 5.33 hazard of overdose the following month, and reductions of 10 percent or less carried none.

Which conversion produced my daily total, and is any buprenorphine counted in it?
Has anyone identified what is generating my pain?
What are my fasting insulin and hemoglobin A1c?
Has my body composition been measured, or only my weight?
If a change is proposed, what is its pace, and who decides when to pause?

Dr. Padda’s own position concedes the uncomfortable half: the milligram is a real hazard, and prescribing did run too high. A physician who ignores the metric is as wrong as one who worships it. What returns control to you is a fuller record, where the number sits beside the measurements that explain it. The next step in the book, what the easiest first treatment takes from a person over years, is covered in what to measure before back surgery.

Frequently asked questions

What does MME mean on my medical record?

It is a daily total that converts each opioid you take into the amount of morphine judged to have a similar effect, then adds them together. It is a conversion, not a lab value, and trained clinicians given the same doses produced widely scattered totals. Treat it as an estimate with error around it. How to read any single number is covered in what a test result can and cannot tell you.

Is a higher MME always more dangerous?

Risk does climb with dose, but gradually, and pooled studies place the start of that climb at 20 milligrams a day rather than at any later line. Other factors, including age over 75, a substance-use disorder and a benzodiazepine taken alongside, carried large increases of their own. Your own results should be read as a whole, as described in understanding your results.

Can blood sugar or genes change how a pain medicine works?

Yes. A liver enzyme decides how much active drug codeine and tramadol become, and poor metabolizers make far less. After joint replacement, one receptor gene’s effect on morphine need reversed direction in people with diabetes. Genetic testing is done elsewhere, but insulin resistance can be measured, and its early pattern is described in what insulin resistance looks like before diabetes.

Does Measura adjust or prescribe pain medication?

No. Measura is a testing service. It measures metabolic, vascular, autonomic, nerve, body composition and cognitive function and sends findings to your physician, who makes every treatment decision, including anything about medication. Testing adds information to that conversation; it does not replace it. Whether testing suits your situation is covered in who should be tested.

What should I ask before any change to my dose?

Ask how your daily total was calculated, what pace any change would follow, who decides when to pause, and whether anyone has looked for the source of the pain. Keep the plan in writing, and do not change a dose on your own. A list of questions for the visit is in questions worth asking your doctor.

What is considered a high MME?

No single line makes a dose safe or dangerous. Pooled dose studies found overdose risk starting to rise at 20 milligrams a day, and in a Washington health plan, people taking 100 milligrams a day or more overdosed at 8.9 times the rate of those at 1 to 20. The 2022 federal guideline states that no dosage threshold makes risk disappear, so the number reads best beside your other measurements.

Why does my pharmacy check my MME?

Because the daily total is one figure a system can read, and it can decide a pharmacy alert, a letter or a quality score. The conversion carries real error: 319 clinicians converting the same 75-microgram fentanyl patch returned a mean of 176 milligrams with a standard deviation of 117. The 2022 federal guideline also says buprenorphine should not be added into the total. Ask which conversion produced yours.

Put measurements beside the number

Ask your physician about metabolic blood work and body composition testing, so decisions about your pain rest on more than a dose total. Measura sends every finding to your physician.

Send a message

4477 Woodson Rd, Suite 201, St. Louis, MO 63134. Monday to Friday, 9:00 a.m. to 5:00 p.m. Please do not send symptoms, diagnoses or images through a web form — a website form is not a secure medical channel. Send your name and number and we will call you back.

References

Dunn, K. M., Saunders, K. W., Rutter, C. M., Banta-Green, C. J., Merrill, J. O., Sullivan, M. D., Weisner, C. M., Silverberg, M. J., Campbell, C. I., Psaty, B. M., & Von Korff, M. (2010). Opioid prescriptions for chronic pain and overdose: a cohort study. Annals of Internal Medicine, 152(2), 85–92. https://doi.org/10.7326/0003-4819-152-2-201001190-00006
Rennick, A., Atkinson, T., Cimino, N. M., Strassels, S. A., McPherson, M. L., & Fudin, J. (2016). Variability in Opioid Equivalence Calculations. Pain Medicine, 17(5), 892–898. https://doi.org/10.1111/pme.12920
Dowell, D., Ragan, K. R., Jones, C. M., Baldwin, G. T., & Chou, R. (2022). CDC Clinical Practice Guideline for Prescribing Opioids for Pain – United States, 2022. MMWR. Recommendations and Reports, 71(3), 1–95. https://doi.org/10.15585/mmwr.rr7103a1
Crews, K. R., Monte, A. A., Huddart, R., Caudle, K. E., Kharasch, E. D., Gaedigk, A., Dunnenberger, H. M., Leeder, J. S., Callaghan, J. T., Samer, C. F., Klein, T. E., Haidar, C. E., Van Driest, S. L., Ruano, G., Sangkuhl, K., Cavallari, L. H., Müller, D. J., Prows, C. A., Nagy, M., … Skaar, T. C. (2021). Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy. Clinical Pharmacology and Therapeutics, 110(4), 888–896. https://doi.org/10.1002/cpt.2149
Jurewicz, A., Gasiorowska, A., Leźnicka, K., Maciejewska-Skrendo, A., Pawlak, M., Machoy-Mokrzyńska, A., Bohatyrewicz, A., & Tarnowski, M. (2025). Do Diabetes and Genetic Polymorphisms in the OPRM1 and COMT Genes Modulate the Postoperative Opioid Demand and Pain Perception in Osteoarthritis Patients After Total Knee and Hip Arthroplasty? Journal of Clinical Medicine, 14(13), 4634. https://doi.org/10.3390/jcm14134634
Lo-Ciganic, W.-H., Huang, J. L., Zhang, H. H., Weiss, J. C., Wu, Y., Kwoh, C. K., Donohue, J. M., Cochran, G., Gordon, A. J., Malone, D. C., Kuza, C. C., & Gellad, W. F. (2019). Evaluation of Machine-Learning Algorithms for Predicting Opioid Overdose Risk Among Medicare Beneficiaries With Opioid Prescriptions. JAMA Network Open, 2(3), e190968. https://doi.org/10.1001/jamanetworkopen.2019.0968
Weiner, S. G., El Ibrahimi, S., Hendricks, M. A., Hallvik, S. E., Hildebran, C., Fischer, M. A., Weiss, R. D., Boyer, E. W., Kreiner, P. W., Wright, D. A., Flores, D. P., & Ritter, G. A. (2022). Factors Associated With Opioid Overdose After an Initial Opioid Prescription. JAMA Network Open, 5(1), e2145691. https://doi.org/10.1001/jamanetworkopen.2021.45691
Hernandez, I., He, M., Brooks, M. M., & Zhang, Y. (2018). Exposure-Response Association Between Concurrent Opioid and Benzodiazepine Use and Risk of Opioid-Related Overdose in Medicare Part D Beneficiaries. JAMA Network Open, 1(2), e180919. https://doi.org/10.1001/jamanetworkopen.2018.0919
Glanz, J. M., Xu, S., Narwaney, K. J., McClure, D. L., Rinehart, D. J., Ford, M. A., Nguyen, A. P., & Binswanger, I. A. (2023). Association Between Opioid Dose Reduction Rates and Overdose Among Patients Prescribed Long-Term Opioid Therapy. Substance Abuse, 44(3), 209–219. https://doi.org/10.1177/08897077231186216